Sign in
Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer
Journal article   Open access  Peer reviewed

Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen–Targeted Imaging Agent for Prostate Cancer

Suzanne E Lapi, Hilla Wahnishe, David Pham, Lisa Y Wu, Jessie R Nedrow-Byers, Tiancheng Liu, Kaveh Vejdani, Henry F VanBrocklin, Clifford E Berkman and Ella F Jones
The Journal of nuclear medicine (1978), Vol.50(12), pp.2042-2048
12/2009
Handle:
https://hdl.handle.net/2376/107214
PMCID: PMC3575752
PMID: 19910433
url
https://doi.org/10.2967/jnumed.109.066589View
Published (Version of record) Open

Abstract

radiopharmaceuticals PSMA prostate cancer phosphoramidate molecular imaging PET 18F

Metrics

7 Record Views

Details